Companies that reported the most in general payments in 2021
The 50 highest-ranked manufacturers and group purchasing organisations, by general payments for program year 2021, out of $3,270,711,176 of that kind reported across the whole year. A ranking is not a judgement, and this list is a slice of the year rather than all of it.
Ranked by reported value
50 shownDownload CSV · 50 rows Free, no sign-in. Raw amounts in U.S. dollars; the second row says where the data came from.
- BioNTech SE 15.8% of the year $517,137,581 · 27 payments
- Medtronic, Inc. 4.4% of the year $143,257,043 · 208,578 payments
- Stryker Corporation 3.5% of the year $114,734,538 · 110,615 payments
- Hill-Rom, Inc 3.4% of the year $110,558,487 · 2 payments
- Genentech, Inc. 3.2% of the year $105,580,623 · 2,008 payments
- AbbVie, Inc. 3% of the year $97,637,830 · 1,333,681 payments
- Zimmer Biomet Holdings, Inc. 2.8% of the year $90,606,108 · 69,805 payments
- Arthrex, Inc. 2.7% of the year $88,508,383 · 36,551 payments
- AstraZeneca Pharmaceuticals LP 2.3% of the year $75,691,974 · 436,207 payments
- DePuy Synthes Products, Inc. 2.1% of the year $69,948,154 · 2,175 payments
- Allergan Inc. 2% of the year $66,652,603 · 192,082 payments
- Takeda Pharmaceuticals U.S.A., Inc. 1.9% of the year $61,365,861 · 216,580 payments
- Intuitive Surgical, Inc. 1.7% of the year $53,880,470 · 68,483 payments
- Henry Schein, Inc. 1.4% of the year $44,731,293 · 1,276 payments
- Pfizer Inc. 1.4% of the year $44,674,069 · 310,507 payments
- Boston Scientific Corporation 1.3% of the year $41,328,709 · 149,097 payments
- Vertex Pharmaceuticals Incorporated 1.2% of the year $40,022,384 · 981 payments
- Genzyme Corporation 1.1% of the year $35,517,553 · 82,120 payments
- Smith+Nephew, Inc. 0.9% of the year $30,029,039 · 59,517 payments
- Abbott Laboratories 0.9% of the year $28,418,734 · 234,595 payments
- Merck Sharp & Dohme Corporation 0.9% of the year $28,234,581 · 213,360 payments
- Novo Nordisk Inc 0.8% of the year $27,303,475 · 473,327 payments
- Amgen Inc. 0.8% of the year $26,565,568 · 364,490 payments
- Lilly USA, LLC 0.8% of the year $25,634,553 · 334,957 payments
- GlaxoSmithKline, LLC. 0.7% of the year $24,003,944 · 307,839 payments
- Encore Medical, LP 0.7% of the year $22,684,884 · 6,853 payments
- Gilead Sciences, Inc. 0.7% of the year $22,662,112 · 88,950 payments
- E.R. Squibb & Sons, L.L.C. 0.6% of the year $20,606,285 · 100,002 payments
- Medical Device Business Services, Inc. 0.6% of the year $18,331,731 · 16,568 payments
- NuVasive, Inc. 0.6% of the year $18,294,772 · 12,729 payments
- CSL Behring 0.5% of the year $17,489,258 · 28,194 payments
- Janssen Pharmaceuticals, Inc 0.5% of the year $17,353,645 · 334,611 payments
- Eisai Inc. 0.5% of the year $17,204,955 · 81,057 payments
- kaleo, Inc. 0.5% of the year $16,187,886 · 12,067 payments
- Boehringer Ingelheim Pharmaceuticals, Inc. 0.5% of the year $15,748,134 · 249,405 payments
- Edwards Lifesciences Corporation 0.5% of the year $15,536,908 · 35,317 payments
- Globus Medical, Inc. 0.5% of the year $14,948,285 · 10,201 payments
- Biogen, Inc. 0.5% of the year $14,835,738 · 54,953 payments
- Walk Vascular, LLC 0.4% of the year $14,324,593 · 45 payments
- LivaNova USA, Inc. 0.4% of the year $14,126,030 · 5,454 payments
- Novartis Pharmaceuticals Corporation 0.4% of the year $13,424,719 · 290,571 payments
- Biohaven Pharmaceuticals, Inc. 0.4% of the year $13,241,717 · 182,745 payments
- Bard Peripheral Vascular, Inc. 0.4% of the year $11,884,139 · 14,808 payments
- Becton, Dickinson and Company 0.4% of the year $11,333,621 · 3,199 payments
- MedShape, Inc. 0.3% of the year $10,956,440 · 293 payments
- Alcon Vision LLC 0.3% of the year $10,780,086 · 63,639 payments
- Galderma Laboratories, L.P. 0.3% of the year $10,256,194 · 49,301 payments
- Alphatec Spine, Inc 0.3% of the year $9,735,718 · 5,351 payments
- Teva Pharmaceuticals USA, Inc. 0.3% of the year $9,641,691 · 108,176 payments
- Regeneron Healthcare Solutions, Inc. 0.3% of the year $9,044,113 · 62,023 payments